Carperitide and adiponectin - How are they connected each other to benefit acute decompensated heart failure?

Circulation Journal

Volumn 73, Issue 12, 2009, Pages 2206-2207

  Asanuma, Hiroshi ^a   Kitakaze, Masafumi ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; GLUCOSE; INSULIN; METFORMIN; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE DECOMPENSATED CHRONIC HEART FAILURE; ACUTE DECOMPENSATED HEART FAILURE; ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ADIPOSE TISSUE; ADRENERGIC SYSTEM; ANTIINFLAMMATORY ACTIVITY; AORTA CONSTRICTION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE SEVERITY; DRUG MECHANISM; EDITORIAL; ENERGY METABOLISM; ENZYME ACTIVATION; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEART ATRIUM MUSCLE; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC DISORDER; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; VASODILATATION;

ACUTE DISEASE; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; DIABETES COMPLICATIONS; ENZYME ACTIVATION; HEART FAILURE; HUMANS; INFUSIONS, PARENTERAL; MYOCARDIAL INFARCTION; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 73349102481     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0785     Document Type: Editorial

References (14)

1. Hata N, Seino Y, Tsutamoto T, Hiramitsu S, Kaneko N, Yoshikawa T, et al. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: The PROTECT multicenter randomized controlled study. Circ J 2008; 72: 1787-1793.
2. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004; 10: 1384-1389.
3. Tanaka T, Tsutamoto T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, et al. Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail 2008; 10: 360-366.
4. Yamaji M, Tsutamoto T, Tanaka T, Kawahara C, Nishiyama K, Yamamoto T, et al. Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure patients with diabetes mellitus. Circ J 2009; 73: 2264-2269.
5. Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, et al. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 2003; 278: 48617-48626.
6. Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, et al. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J 2004; 18: 908-910.
7. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 2009; 53: 2070-2077.
8. Hardie DG. AMP-activated protein kinase: The guardian of cardiac energy status. J Clin Invest 2004; 114: 465-468.
9. Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: Systematic review. BMJ 2007; 335: 497.
10. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174.
11. Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, et al. Metformin prevents progression of heart failure in dogs: Role of AMP-activated protein kinase. Circulation 2009; 119: 2568-2577.
12. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-1295.
13. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, et al; J-WIND investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): Two randomised trials. Lancet 2007; 370: 1483-1493.
14. Kojima S, Funahashi T, Sakamoto T, Miyamoto S, Soejima H, Hokamaki J, et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003; 89: 667.